Literature DB >> 15664999

Oxidative stress-mediated, post-translational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells.

Jamie S Harmon1, Roland Stein, R Paul Robertson.   

Abstract

Glucose toxicity in pancreatic islet beta cells causes loss of insulin gene expression, content, and secretion due to loss of binding of transcription factors, most notably PDX-1 and RIPE-3b1 activator, to the promoter region of the insulin gene. Recently, RIPE-3b1 activator was cloned and identified as the mammalian homologue of avian MafA/Maf-L (MafA). This enabled us to carry out more extensive studies of the role of MafA in glucotoxicity than were hitherto possible. Northern analysis of glucotoxic HIT-T15 cells revealed normal amounts of MafA mRNA, but Western analysis demonstrated a 97 +/- 1% reduction in MafA protein (p < 0.0001). The proteasome is a likely site for MafA degradation as lactacystin, an irreversible proteasome inhibitor, caused an accumulation of MafA protein. Antioxidants have previously been shown to prevent the adverse effects of glucose toxicity on beta cell function both in vivo and in vitro. In the current study, chronic culturing of HIT-T15 cells with the antioxidant N-acetylcysteine (NAC) prevented loss of MafA protein (late passage = 18.9 +/- 10.4% of early passage, p < 0.001; late passage with NAC = 68.7 +/- 19.7% of early passage, p = not significant) and loss of DNA binding (late passage = 63.7 +/- 9% of early passage, p < 0.02; late passage with NAC = 116 +/- 10% of early passage, p = not significant). Additionally, transient transfection of PDX-1 or MafA cDNA into glucotoxic cells increased PDX-1 and MafA protein levels and individually increased insulin promoter activity (untreated = 34%, PDX-1 = 70%, MafA = 78%; percentage of activity of early passage cells), whereas the combined transfection of MafA and PDX-1 completely restored insulin promoter activity. This recovery of promoter activity following transient transfection had no effect on endogenous insulin mRNA. However, adenoviral infection of MafA and PDX-1 significantly increased endogenous insulin mRNA levels by 93% (121 +/- 9 versus 233 +/- 18 density light units; n = 5, p < 0.001). We conclude that the absence of MafA protein from beta cells via chronic oxidative stress contributes importantly to the loss of endogenous insulin gene expression as glucose toxicity develops.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664999     DOI: 10.1074/jbc.M410345200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  93 in total

1.  An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells.

Authors:  Jeffrey M Sturek; J David Castle; Anthony P Trace; Laura C Page; Anna M Castle; Carmella Evans-Molina; John S Parks; Raghavendra G Mirmira; Catherine C Hedrick
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

2.  Mitochondrial oxidative stress contributes differently to rat pancreatic islet cell apoptosis and insulin secretory defects after prolonged culture in a low non-stimulating glucose concentration.

Authors:  L P Roma; S M Pascal; J Duprez; J-C Jonas
Journal:  Diabetologia       Date:  2012-05-29       Impact factor: 10.122

Review 3.  Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2015-12       Impact factor: 1.894

4.  B lymphocytes protect islet β cells in diabetes prone NOD mice treated with imatinib.

Authors:  Christopher S Wilson; Jason M Spaeth; Jay Karp; Blair T Stocks; Emilee M Hoopes; Roland W Stein; Daniel J Moore
Journal:  JCI Insight       Date:  2019-04-09

Review 5.  Glucolipotoxicity: fuel excess and beta-cell dysfunction.

Authors:  Vincent Poitout; R Paul Robertson
Journal:  Endocr Rev       Date:  2007-11-29       Impact factor: 19.871

6.  TFP5, a peptide derived from p35, a Cdk5 neuronal activator, rescues cortical neurons from glucose toxicity.

Authors:  B K Binukumar; Ya-Li Zheng; Varsha Shukla; Niranjana D Amin; Philip Grant; Harish C Pant
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

7.  Decreased levels of metabolic enzymes in pancreatic islets of patients with type 2 diabetes.

Authors:  M J MacDonald; M J Longacre; E-C Langberg; A Tibell; M A Kendrick; T Fukao; C-G Ostenson
Journal:  Diabetologia       Date:  2009-03-19       Impact factor: 10.122

8.  Multiple chromatin-bound protein kinases assemble factors that regulate insulin gene transcription.

Authors:  Michael C Lawrence; Chunli Shao; Kathleen McGlynn; Bashoo Naziruddin; Marlon F Levy; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-16       Impact factor: 11.205

Review 9.  Understanding Genetic Heterogeneity in Type 2 Diabetes by Delineating Physiological Phenotypes: SIRT1 and its Gene Network in Impaired Insulin Secretion.

Authors:  Shafat Ali; Shazia Nafis; Ponnusamy Kalaiarasan; Ekta Rai; Swarkar Sharma; Rameshwar N Bamezai
Journal:  Rev Diabet Stud       Date:  2016-05-10

10.  Beta cell nuclear musculoaponeurotic fibrosarcoma oncogene family A (MafA) is deficient in type 2 diabetes.

Authors:  A E Butler; R P Robertson; R Hernandez; A V Matveyenko; T Gurlo; P C Butler
Journal:  Diabetologia       Date:  2012-07-31       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.